| Recruitment status | Enrolling by invitation |
| Unique ID issued by UMIN | UMIN000040579 |
| Receipt No. | R000046317 |
| Scientific Title | Effect of smoking on sympathetic nerve activity in heart failure |
| Date of disclosure of the study information | 2020/05/29 |
| Last modified on | 2020/05/29 (Ver. 1) |
| Basic information | ||
| Public title | Effect of smoking on sympathetic nerve activity in heart failure | |
| Acronym | Smoking status in heart failure | |
| Scientific Title | Effect of smoking on sympathetic nerve activity in heart failure | |
| Scientific Title:Acronym | SMOKEHF | |
| Region |
|
|
| Condition | ||
| Condition | heart failure patients | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | It is well-known that smoking habit contribute to cardiovascuoler event. smoking is also reported to Increased sympathetic nerve activity. Recently electrical cigarrete is spreading, but its effect on sympathetic nerve activity is unclear |
| Basic objectives2 | Others |
| Basic objectives -Others | In this study, we examine the effect of electrical and nonelectrical smoking on muscle sympathetic nerve activity. |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Explanatory |
| Developmental phase | Phase I |
| Assessment | |
| Primary outcomes | decrease in MSNA |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | HF patients is defined as HF symptom, BNP>100pg/ml and left ventricular dysfunction before medication.
Smoking habit over 1years |
|||
| Key exclusion criteria | 1)diagnosis of HF within 1 month
2)Hemo-dialysis state 3)Uncontroled diabetes patients(HbA1c>8.0) 4)Severe autonomic dysfuntion 5)an inappropriate patient |
|||
| Target sample size | 45 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Katy Graduate School of Medical Sciencesnazawa University | ||||||
| Division name | Department of Cardiovascular Medicine | ||||||
| Zip code | 9208641 | ||||||
| Address | 13-1 Takara-machi, Kanazawa | ||||||
| TEL | 076265200 | ||||||
| sakurasoma1209@yahoo.co.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Katy Graduate School of Medical Sciencesnazawa University | ||||||
| Division name | Department of Cardiovascular Medicine | ||||||
| Zip code | 9208641 | ||||||
| Address | 13-1 Takara-machi, Kanazawa | ||||||
| TEL | 076265200 | ||||||
| Homepage URL | |||||||
| sakurasoma1209@yahoo.co.jp | |||||||
| Sponsor | |
| Institute | Department of Cardiovascular Medicine, Kanazawa University Graduate School of Medical Sciences |
| Institute | |
| Department | |
| Funding Source | |
| Organization | self funding |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Institutional Review Board |
| Address | 13-1 Takara-machi, Kanazawa |
| Tel | 0762652110 |
| rinri@adm.kanazawa-u.ac.jp | |
| Secondary IDs | |
| Secondary IDs | YES |
| Study ID_1 | 2019-077 (3116) |
| Org. issuing International ID_1 | 2019-077 (3116) |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Enrolling by invitation | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | N/A |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046317 |